HEADER CELL ADHESION 27-JUL-10 2L1C TITLE SHC-PTB:BIPHOSPHORYLATED INTEGRIN BETA3 CYTOPLASMIC TAIL COMPLEX (1:1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SHC (SRC HOMOLOGY 2 DOMAIN CONTAINING) TRANSFORMING PROTEIN COMPND 3 1, ISOFORM CRA_D; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: PTB DOMAIN (UNP RESIDUES 17-207); COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INTEGRIN BETA-3; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 762-788; COMPND 11 SYNONYM: PLATELET MEMBRANE GLYCOPROTEIN IIIA, GPIIIA; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SHC1, HCG_1997126; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED BASED ON THE SOURCE 12 SEQUENCE OF THE HUMAN INTEGRIN BETA3 CYTOPLASMIC TAIL (REPRESENTING SOURCE 13 RESIDUES 736R-762G) KEYWDS SHC-PTB, INTEGRIN BETA3, CYTOPLASMIC TAIL, CELL ADHESION EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR L.DESHMUKH,V.GORBATYUK,O.VINOGRADOVA REVDAT 3 18-APR-12 2L1C 1 JRNL VERSN ATOM REVDAT 2 08-SEP-10 2L1C 1 JRNL REVDAT 1 18-AUG-10 2L1C 0 JRNL AUTH L.DESHMUKH,V.GORBATYUK,O.VINOGRADOVA JRNL TITL INTEGRIN {BETA}3 PHOSPHORYLATION DICTATES ITS COMPLEX WITH JRNL TITL 2 THE SHC PHOSPHOTYROSINE-BINDING (PTB) DOMAIN. JRNL REF J.BIOL.CHEM. V. 285 34875 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20739287 JRNL DOI 10.1074/JBC.M110.159087 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.21 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT IN EXPLICIT WATER REMARK 4 REMARK 4 2L1C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUL-10. REMARK 100 THE RCSB ID CODE IS RCSB101832. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.4 MM [U-99% 13C; U-99% 15N] REMARK 210 SHC, 0.8 MM INTEGRIN BETA3, 5 MM REMARK 210 DTT, 50 MM SODIUM CHLORIDE, 50 MM REMARK 210 SODIUM PHOSPHATE, 1 MM DSS, 93% REMARK 210 H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D HNCA; 3D HNCACB; 3D REMARK 210 HBHA(CO)NH; 3D 1H-15N EDITED REMARK 210 NOESY; 3D 1H-13C EDITED NOESY; 3D REMARK 210 HNCACO; 3D 1H-13C AROMATIC NOESY; REMARK 210 2D 13C,15N FILTEREDTOCSY; 2D 13C, REMARK 210 15N FILTERED NOESY; 3D F1 13C,15N REMARK 210 FILTERED, F2 13C EDITED NOESY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1, NMRPIPE, VNMRJ, CCPN- REMARK 210 ANALYSIS 2.1.3 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 80 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 SER A 6 REMARK 465 SER A 7 REMARK 465 GLY A 8 REMARK 465 LEU A 9 REMARK 465 VAL A 10 REMARK 465 PRO A 11 REMARK 465 ARG A 12 REMARK 465 GLY A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 MET A 16 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HA PRO A 183 HD22 LEU A 186 1.15 REMARK 500 H LYS A 100 HD12 LEU B 746 1.18 REMARK 500 HB2 ARG A 74 HE2 PHE A 152 1.27 REMARK 500 HB2 SER A 127 HB2 SER A 130 1.32 REMARK 500 HZ1 LYS A 93 OE2 GLU A 181 1.57 REMARK 500 HZ2 LYS A 100 O1P PTR B 747 1.59 REMARK 500 HH21 ARG A 55 OE1 GLU A 181 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 88 -54.48 -148.24 REMARK 500 1 ARG A 97 88.13 60.93 REMARK 500 1 PRO A 101 -74.53 -60.27 REMARK 500 1 LEU A 106 -48.18 -133.84 REMARK 500 1 SER A 107 25.14 -151.96 REMARK 500 1 LEU A 110 -157.34 -102.43 REMARK 500 1 CYS A 138 33.34 71.13 REMARK 500 1 LYS A 139 -61.93 -92.47 REMARK 500 1 GLN A 140 -164.56 176.31 REMARK 500 1 ALA A 143 -158.99 66.22 REMARK 500 1 SER A 151 -73.44 -146.80 REMARK 500 1 ASP A 157 52.81 -143.95 REMARK 500 1 VAL A 172 -62.30 -107.26 REMARK 500 1 ALA A 187 -74.05 -47.87 REMARK 500 1 LYS B 738 -77.80 -102.11 REMARK 500 1 TRP B 739 -52.67 170.71 REMARK 500 1 ALA B 742 154.71 172.95 REMARK 500 1 ASN B 744 -177.18 -170.08 REMARK 500 1 ALA B 750 80.05 -175.30 REMARK 500 1 THR B 751 173.81 168.38 REMARK 500 1 THR B 755 -85.79 -152.85 REMARK 500 1 ASN B 756 -166.78 -168.40 REMARK 500 1 THR B 758 -58.13 -120.58 REMARK 500 2 ALA A 88 -51.93 -149.07 REMARK 500 2 ARG A 97 86.37 71.04 REMARK 500 2 SER A 103 57.34 -117.22 REMARK 500 2 PRO A 105 -75.78 -62.93 REMARK 500 2 LEU A 106 -53.30 -128.73 REMARK 500 2 SER A 107 17.02 -145.30 REMARK 500 2 LEU A 110 -155.97 -95.28 REMARK 500 2 LYS A 139 -66.52 -91.00 REMARK 500 2 GLN A 140 -160.71 -172.81 REMARK 500 2 ALA A 143 -166.73 71.33 REMARK 500 2 HIS A 145 30.24 -90.04 REMARK 500 2 SER A 149 42.66 -81.84 REMARK 500 2 ILE A 150 -167.55 -112.42 REMARK 500 2 SER A 151 -70.84 -143.00 REMARK 500 2 ASP A 157 57.81 -146.16 REMARK 500 2 ASN A 173 -156.82 -141.92 REMARK 500 2 GLN A 174 -81.90 -90.90 REMARK 500 2 ALA A 187 -71.46 -50.05 REMARK 500 2 ALA B 742 158.22 177.96 REMARK 500 2 ASN B 743 113.56 -165.57 REMARK 500 2 PRO B 745 87.42 -64.36 REMARK 500 2 LEU B 746 -38.76 170.48 REMARK 500 2 ALA B 750 30.42 -164.75 REMARK 500 2 ARG B 760 125.36 -174.52 REMARK 500 3 LYS A 33 83.51 -156.33 REMARK 500 3 PRO A 34 -141.97 -94.21 REMARK 500 3 ARG A 36 55.61 -102.05 REMARK 500 REMARK 500 THIS ENTRY HAS 372 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2L1C A 17 207 UNP D3DV78 D3DV78_HUMAN 17 207 DBREF 2L1C B 736 762 UNP P05106 ITB3_HUMAN 762 788 SEQADV 2L1C GLY A -3 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C SER A -2 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C SER A -1 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 0 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 1 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 2 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 3 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 4 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 5 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C SER A 6 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C SER A 7 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C GLY A 8 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C LEU A 9 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C VAL A 10 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C PRO A 11 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C ARG A 12 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C GLY A 13 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C SER A 14 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C HIS A 15 UNP D3DV78 EXPRESSION TAG SEQADV 2L1C MET A 16 UNP D3DV78 EXPRESSION TAG SEQRES 1 A 211 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 211 VAL PRO ARG GLY SER HIS MET GLY GLN LEU GLY GLY GLU SEQRES 3 A 211 GLU TRP THR ARG HIS GLY SER PHE VAL ASN LYS PRO THR SEQRES 4 A 211 ARG GLY TRP LEU HIS PRO ASN ASP LYS VAL MET GLY PRO SEQRES 5 A 211 GLY VAL SER TYR LEU VAL ARG TYR MET GLY CYS VAL GLU SEQRES 6 A 211 VAL LEU GLN SER MET ARG ALA LEU ASP PHE ASN THR ARG SEQRES 7 A 211 THR GLN VAL THR ARG GLU ALA ILE SER LEU VAL CYS GLU SEQRES 8 A 211 ALA VAL PRO GLY ALA LYS GLY ALA THR ARG ARG ARG LYS SEQRES 9 A 211 PRO CYS SER ARG PRO LEU SER SER ILE LEU GLY ARG SER SEQRES 10 A 211 ASN LEU LYS PHE ALA GLY MET PRO ILE THR LEU THR VAL SEQRES 11 A 211 SER THR SER SER LEU ASN LEU MET ALA ALA ASP CYS LYS SEQRES 12 A 211 GLN ILE ILE ALA ASN HIS HIS MET GLN SER ILE SER PHE SEQRES 13 A 211 ALA SER GLY GLY ASP PRO ASP THR ALA GLU TYR VAL ALA SEQRES 14 A 211 TYR VAL ALA LYS ASP PRO VAL ASN GLN ARG ALA CYS HIS SEQRES 15 A 211 ILE LEU GLU CYS PRO GLU GLY LEU ALA GLN ASP VAL ILE SEQRES 16 A 211 SER THR ILE GLY GLN ALA PHE GLU LEU ARG PHE LYS GLN SEQRES 17 A 211 TYR LEU ARG SEQRES 1 B 27 ARG ALA LYS TRP ASP THR ALA ASN ASN PRO LEU PTR LYS SEQRES 2 B 27 GLU ALA THR SER THR PHE THR ASN ILE THR PTR ARG GLY SEQRES 3 B 27 THR MODRES 2L1C PTR B 747 TYR O-PHOSPHOTYROSINE MODRES 2L1C PTR B 759 TYR O-PHOSPHOTYROSINE HET PTR B 747 24 HET PTR B 759 24 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR 2(C9 H12 N O6 P) HELIX 1 1 LEU A 39 GLY A 47 1 9 HELIX 2 2 ASP A 70 GLU A 87 1 18 HELIX 3 3 HIS A 146 GLN A 148 5 3 HELIX 4 4 GLY A 185 LEU A 200 1 16 SHEET 1 A 7 ILE A 141 ASN A 144 0 SHEET 2 A 7 SER A 130 ALA A 135 -1 N LEU A 133 O ILE A 142 SHEET 3 A 7 ARG A 112 SER A 127 -1 N SER A 127 O SER A 130 SHEET 4 A 7 VAL A 50 GLU A 61 -1 N TYR A 56 O MET A 120 SHEET 5 A 7 ALA A 176 GLU A 181 -1 O ILE A 179 N MET A 57 SHEET 6 A 7 VAL A 164 ALA A 168 -1 N TYR A 166 O HIS A 178 SHEET 7 A 7 ILE A 150 SER A 154 -1 N PHE A 152 O VAL A 167 LINK C LEU B 746 N PTR B 747 1555 1555 1.32 LINK C PTR B 747 N LYS B 748 1555 1555 1.31 LINK C THR B 758 N PTR B 759 1555 1555 1.32 LINK C PTR B 759 N ARG B 760 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1